CANADA: A Game Changer for First-in-Human Trials
Get Ahead of the Competition
Looking to take your ex-U.S. strategy to the next level? With a state-of-the-art clinical facility in Canada, Altasciences has the capacity and decades of expertise to submit your CTA six to nine weeks earlier than an IND.
We can help get you into the clinic faster—schedule a chat today!
|Co-located Canadian Ophthalmology Center for All Your Early Phase Development Needs
|Accelerate Your Data With Our Canadian Co-located Clinic and Lab
|Montréal Clinic Mini Tour